vs
Concentrix Corp（CNXC）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
Concentrix Corp的季度营收约是瑞思迈的1.8倍（$2.6B vs $1.4B），瑞思迈净利率更高（27.6% vs -57.9%，领先85.5%），瑞思迈同比增速更快（11.0% vs 4.3%），瑞思迈自由现金流更多（$311.2M vs $281.2M），过去两年瑞思迈的营收复合增速更高（9.0% vs 3.1%）
Concentrix是总部位于美国加利福尼亚州纽瓦克的业务流程外包服务商，2006年起成为SYNNEX集团旗下子公司，2020年12月1日独立上市，2025年位列《财富》美国500强第426位，为全球客户提供专业的外包解决方案支持。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
CNXC vs RMD — 直观对比
营收规模更大
CNXC
是对方的1.8倍
$1.4B
营收增速更快
RMD
高出6.7%
4.3%
净利率更高
RMD
高出85.5%
-57.9%
自由现金流更多
RMD
多$30.0M
$281.2M
两年增速更快
RMD
近两年复合增速
3.1%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.6B | $1.4B |
| 净利润 | $-1.5B | $392.6M |
| 毛利率 | 34.3% | 61.8% |
| 营业利润率 | -54.1% | 34.6% |
| 净利率 | -57.9% | 27.6% |
| 营收同比 | 4.3% | 11.0% |
| 净利润同比 | -1379.2% | 13.9% |
| 每股收益（稀释后） | $-23.37 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CNXCRMD
| Q4 25 | $2.6B | $1.4B | ||
| Q3 25 | $2.5B | $1.3B | ||
| Q2 25 | $2.4B | $1.3B | ||
| Q1 25 | $2.4B | $1.3B | ||
| Q4 24 | $2.4B | $1.3B | ||
| Q3 24 | $2.4B | $1.2B | ||
| Q2 24 | $2.4B | $1.2B | ||
| Q1 24 | $2.4B | $1.2B |
净利润CNXCRMD
| Q4 25 | $-1.5B | $392.6M | ||
| Q3 25 | $88.1M | $348.5M | ||
| Q2 25 | $42.1M | $379.7M | ||
| Q1 25 | $70.3M | $365.0M | ||
| Q4 24 | $115.7M | $344.6M | ||
| Q3 24 | $16.6M | $311.4M | ||
| Q2 24 | $66.8M | $292.2M | ||
| Q1 24 | $52.1M | $300.5M |
毛利率CNXCRMD
| Q4 25 | 34.3% | 61.8% | ||
| Q3 25 | 34.4% | 61.5% | ||
| Q2 25 | 35.1% | 60.8% | ||
| Q1 25 | 36.1% | 59.3% | ||
| Q4 24 | 35.6% | 58.6% | ||
| Q3 24 | 36.2% | 58.6% | ||
| Q2 24 | 36.0% | 58.5% | ||
| Q1 24 | 35.6% | 57.9% |
营业利润率CNXCRMD
| Q4 25 | -54.1% | 34.6% | ||
| Q3 25 | 5.9% | 33.4% | ||
| Q2 25 | 6.1% | 33.7% | ||
| Q1 25 | 7.1% | 33.0% | ||
| Q4 24 | 5.9% | 32.5% | ||
| Q3 24 | 6.4% | 31.6% | ||
| Q2 24 | 6.3% | 31.2% | ||
| Q1 24 | 6.2% | 31.3% |
净利率CNXCRMD
| Q4 25 | -57.9% | 27.6% | ||
| Q3 25 | 3.5% | 26.1% | ||
| Q2 25 | 1.7% | 28.2% | ||
| Q1 25 | 3.0% | 28.3% | ||
| Q4 24 | 4.7% | 26.9% | ||
| Q3 24 | 0.7% | 25.4% | ||
| Q2 24 | 2.8% | 23.9% | ||
| Q1 24 | 2.2% | 25.1% |
每股收益（稀释后）CNXCRMD
| Q4 25 | $-23.37 | $2.68 | ||
| Q3 25 | $1.34 | $2.37 | ||
| Q2 25 | $0.63 | $2.58 | ||
| Q1 25 | $1.04 | $2.48 | ||
| Q4 24 | $1.72 | $2.34 | ||
| Q3 24 | $0.25 | $2.11 | ||
| Q2 24 | $0.98 | $1.97 | ||
| Q1 24 | $0.76 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $327.3M | $1.4B |
| 总债务越低越好 | $4.6B | $403.9M |
| 股东权益账面价值 | $2.7B | $6.3B |
| 总资产 | $10.8B | $8.5B |
| 负债/权益比越低杠杆越低 | 1.67× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资CNXCRMD
| Q4 25 | $327.3M | $1.4B | ||
| Q3 25 | $350.3M | $1.4B | ||
| Q2 25 | $342.8M | $1.2B | ||
| Q1 25 | $308.0M | $932.7M | ||
| Q4 24 | $240.6M | $521.9M | ||
| Q3 24 | $246.2M | $426.4M | ||
| Q2 24 | $207.3M | $238.4M | ||
| Q1 24 | $234.8M | $237.9M |
总债务CNXCRMD
| Q4 25 | $4.6B | $403.9M | ||
| Q3 25 | $4.8B | $408.7M | ||
| Q2 25 | $4.9B | $658.4M | ||
| Q1 25 | $4.9B | $663.1M | ||
| Q4 24 | $4.7B | $662.9M | ||
| Q3 24 | $4.9B | $667.6M | ||
| Q2 24 | $4.9B | $697.3M | ||
| Q1 24 | $5.0B | $997.0M |
股东权益CNXCRMD
| Q4 25 | $2.7B | $6.3B | ||
| Q3 25 | $4.3B | $6.1B | ||
| Q2 25 | $4.3B | $6.0B | ||
| Q1 25 | $4.0B | $5.5B | ||
| Q4 24 | $4.0B | $5.3B | ||
| Q3 24 | $4.2B | $5.2B | ||
| Q2 24 | $4.1B | $4.9B | ||
| Q1 24 | $4.1B | $4.6B |
总资产CNXCRMD
| Q4 25 | $10.8B | $8.5B | ||
| Q3 25 | $12.4B | $8.3B | ||
| Q2 25 | $12.4B | $8.2B | ||
| Q1 25 | $11.9B | $7.6B | ||
| Q4 24 | $12.0B | $7.1B | ||
| Q3 24 | $12.2B | $7.2B | ||
| Q2 24 | $12.1B | $6.9B | ||
| Q1 24 | $12.2B | $6.8B |
负债/权益比CNXCRMD
| Q4 25 | 1.67× | 0.06× | ||
| Q3 25 | 1.10× | 0.07× | ||
| Q2 25 | 1.14× | 0.11× | ||
| Q1 25 | 1.22× | 0.12× | ||
| Q4 24 | 1.17× | 0.13× | ||
| Q3 24 | 1.18× | 0.13× | ||
| Q2 24 | 1.21× | 0.14× | ||
| Q1 24 | 1.23× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $344.2M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $281.2M | $311.2M |
| 自由现金流率自由现金流/营收 | 11.0% | 21.9% |
| 资本支出强度资本支出/营收 | 2.5% | 2.0% |
| 现金转化率经营现金流/净利润 | — | 0.87× |
| 过去12个月自由现金流最近4个季度 | $572.5M | $1.8B |
8季度趋势，按日历期对齐
经营现金流CNXCRMD
| Q4 25 | $344.2M | $339.7M | ||
| Q3 25 | $224.8M | $457.3M | ||
| Q2 25 | $236.5M | $538.8M | ||
| Q1 25 | $1.4M | $578.7M | ||
| Q4 24 | $284.4M | $308.6M | ||
| Q3 24 | $191.6M | $325.5M | ||
| Q2 24 | $238.3M | $440.1M | ||
| Q1 24 | $-46.9M | $402.0M |
自由现金流CNXCRMD
| Q4 25 | $281.2M | $311.2M | ||
| Q3 25 | $159.7M | $414.4M | ||
| Q2 25 | $180.7M | $508.2M | ||
| Q1 25 | $-49.2M | $557.9M | ||
| Q4 24 | $224.5M | $288.0M | ||
| Q3 24 | $128.9M | $307.7M | ||
| Q2 24 | $178.3M | $415.2M | ||
| Q1 24 | $-102.9M | $380.8M |
自由现金流率CNXCRMD
| Q4 25 | 11.0% | 21.9% | ||
| Q3 25 | 6.4% | 31.0% | ||
| Q2 25 | 7.5% | 37.7% | ||
| Q1 25 | -2.1% | 43.2% | ||
| Q4 24 | 9.2% | 22.5% | ||
| Q3 24 | 5.4% | 25.1% | ||
| Q2 24 | 7.5% | 33.9% | ||
| Q1 24 | -4.3% | 31.8% |
资本支出强度CNXCRMD
| Q4 25 | 2.5% | 2.0% | ||
| Q3 25 | 2.6% | 3.2% | ||
| Q2 25 | 2.3% | 2.3% | ||
| Q1 25 | 2.1% | 1.6% | ||
| Q4 24 | 2.4% | 1.6% | ||
| Q3 24 | 2.6% | 1.5% | ||
| Q2 24 | 2.5% | 2.0% | ||
| Q1 24 | 2.3% | 1.8% |
现金转化率CNXCRMD
| Q4 25 | — | 0.87× | ||
| Q3 25 | 2.55× | 1.31× | ||
| Q2 25 | 5.62× | 1.42× | ||
| Q1 25 | 0.02× | 1.59× | ||
| Q4 24 | 2.46× | 0.90× | ||
| Q3 24 | 11.52× | 1.05× | ||
| Q2 24 | 3.57× | 1.51× | ||
| Q1 24 | -0.90× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CNXC
| Technology And Consumer Electronics | $675.1M | 26% |
| Retail Travel And Ecommerce | $643.4M | 25% |
| Communications And Media | $417.2M | 16% |
| Banking Financial Services And Insurance | $402.6M | 16% |
| Other Industries | $229.7M | 9% |
| Other | $185.0M | 7% |
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
